Cargando…

Facial emotional processing deficits in long-term HIV-suppressed patients

INTRODUCTION: Emotional processing is basic for social behaviour. We examine for the first time the facial emotion processing in long-term HIV-suppressed patients. MATERIALS AND METHODS: Cross-sectional study comparing (ANOVA) six facial emotional processing tasks (two discrimination, two memory and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gonzalez-Baeza, Alicia, Perez-Valero, Ignacio, Carvajal-Molina, Fernando, Bayon, Carmen, Montes-Ramirez, Marisa, Ignacio Bernardino, Jose, Arribas, Jose R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International AIDS Society 2014
Materias:	Poster Sessions – Abstract P132
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225362/ https://www.ncbi.nlm.nih.gov/pubmed/25397414 http://dx.doi.org/10.7448/IAS.17.4.19664

Ejemplares similares

Cerebral volumes, neuronal integrity and brain inflammation measured by MRI in patients receiving PI monotherapy or triple therapy
por: Pérez Valero, Ignacio, et al.
Publicado: (2014)

Impact de la pandémie COVID-19 sur le suivi des patients asthmatiques
por: Ghourabi, A., et al.
Publicado: (2022)

CNS safety at 48-week of switching to ATV/r plus 3TC or two nucleos(t)ides in HIV-suppressed patients on stable ART: the SALT neurocognitive sub-study
por: Pérez Valero, Ignacio, et al.
Publicado: (2014)

Analysis of factors related to shoulder instability in young handball players
por: Torres, Cláudia, et al.
Publicado: (2021)

Efficacy and tolerability of telaprevir (TVR)-based triple therapy in HIV/HCV-coinfected patients
por: De Los Santos, Ignacio, et al.
Publicado: (2014)

Renal safety profile of STB in virologically suppressed subjects from two randomized phase 3b switch trials
por: Reeves, Iain, et al.
Publicado: (2014)

Efficacy of a dual therapy based on darunavir/ritonavir and etravirine in ART-experienced patients
por: Ignacio Bernardino, Jose, et al.
Publicado: (2014)

Comparison of oxidative stress markers in HIV-infected patients on efavirenz or atazanavir/ritonavir-based therapy
por: Estrada, Vicente, et al.
Publicado: (2014)

Simplification to Stribild vs continuation of RTV-boosted DRV with FTC and TDF in virologically suppressed HIV adults: a STRATEGY-PI subgroup analysis
por: Arribas, Jose, et al.
Publicado: (2014)

Neurocognitive Impairment in Patients Treated with Protease Inhibitor Monotherapy or Triple Drug Antiretroviral Therapy
por: Pérez-Valero, Ignacio, et al.
Publicado: (2013)

Low clinical relevance of risky alcohol consumption in a selected group of high adherent HIV-infected patients attended in the United Kingdom
por: Gonzalez Baeza, Alicia, et al.
Publicado: (2014)

Cost/efficacy analysis of preferred Spanish AIDS study group regimens and the dual therapy with LPV/r+3TC for initial ART in HIV infected adults
por: Gatell, Josép M, et al.
Publicado: (2014)

The CD4:CD8 ratio is associated with IMT progression in HIV-infected patients on antiretroviral treatment
por: Bernal, Enrique, et al.
Publicado: (2014)

Resistance mutations in protease gene at baseline are not related to virological failure in patients treated with darunavir/ritonavir monotherapy
por: Gutierrez-Liarte, Angela, et al.
Publicado: (2014)

Changes in lipid levels after 48 weeks of dual versus triple therapy observed in the GARDEL study
por: Cahn, Pedro, et al.
Publicado: (2014)

Efficacy of PI monotherapy versus triple therapy for 1964 patients in 10 randomised trials
por: Arribas, Jose, et al.
Publicado: (2014)

Telaprevir combination therapy in HCV/HIV co-infected patients (INSIGHT study): sustained virologic response at 12 weeks final analysis
por: Montes, Marisa, et al.
Publicado: (2014)

Granulomatose faciale 38 ans après des injections de produits de comblement : rôle précipitant de la COVID-19 et intérêt du méthotrexate
por: Bernigaud, Charlotte, et al.
Publicado: (2021)

Unboosted atazanavir with lamivudine/emtricitabine for patients with long-lasting virological suppression
por: Carbone, Alessia, et al.
Publicado: (2014)

Currently available medications may not be sufficient for lifelong treatment of HIV
por: Jansson, J, et al.
Publicado: (2012)

567 Outcomes of an Education Program on the Rehabilitation of Face and Neck Burns
por: Knight, Deborah, et al.
Publicado: (2023)

568 Mobilization, Splinting & Positioning: Increasing Nursing Participation in the Rehabilitation Plan of Care
por: Knight, Deborah, et al.
Publicado: (2023)

572 Trace Element Supplementation in Burn Patients: A Quality Improvement Project
por: Kurjatko, Alexander, et al.
Publicado: (2023)

571 Effectiveness of Compression Garments with Silicone versus Compression Garments Alone on Hypertrophic Scar
por: Robertson, Karen, et al.
Publicado: (2023)

570 Effectiveness of Hand Edema Management Strategies in the Acute Burn Patient
por: Warthman, Renee, et al.
Publicado: (2023)

566 Posterior Spinal Cord Syndrome after High Voltage Electrical Injury
por: Rodgers, Ariel, et al.
Publicado: (2023)

Switch to raltegravir-based regimens and HIV DNA decrease in patients with suppressed HIV RNA
por: Bianco, Claudia, et al.
Publicado: (2014)

Lipid changes in HIV-patients switching to the coformulated single tablet FTC/RPV/TDF (Eviplera(®)). Efficacy and safety analysis. GeSida Study 8114
por: Pérez-Hernández, Isabel A, et al.
Publicado: (2014)

Nuke-sparing regimens as a main simplification strategy and high level of toxicity resolution after antiretroviral switch: the SWITCHART Study
por: Carrero-Gras, Ana, et al.
Publicado: (2014)

Improvement of endothelial function after switching previously treated HIV-infected patients to an NRTI-sparing bitherapy with maraviroc
por: Bernal, Enrique, et al.
Publicado: (2014)

Structural-equation-modelling of the tropism impact on achieving viral suppression within six months in naïve HIV patients
por: Mengoli, Carlo, et al.
Publicado: (2014)

Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort
por: Pinnetti, Carmela, et al.
Publicado: (2014)

Switching from ritonavir to cobicistat in HIV patients with renal impairment who are virologically suppressed on a protease inhibitor
por: Fisher, Martin, et al.
Publicado: (2014)

CSF LPV concentrations and viral load in viral suppressed patients on LPV/r monotherapy given once daily
por: Tiraboschi, Juan, et al.
Publicado: (2014)

Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy: a cross-sectional study
por: Estébanez, Miriam, et al.
Publicado: (2014)

Liver Fibrosis progression using Fibroscan in HIV/HCV coinfected patients with undetectable HIV viral load
por: Perez-Martinez, Laura, et al.
Publicado: (2014)

The absolute lymphocyte count accurately estimates CD4 counts in HIV-infected adults with virologic suppression and immune reconstitution
por: Young, Barnaby, et al.
Publicado: (2014)

Socio-economic factors and virological suppression among people diagnosed with HIV in the United Kingdom: results from the ASTRA study
por: Burch, Lisa, et al.
Publicado: (2014)

A clinical and pharmacokinetic study of the combination of etravirine plus raltegravir in HIV patients with expanded intolerance or resistance
por: Bañón, Sara, et al.
Publicado: (2014)

Long term effectiveness of once-daily unboosted atazanavir plus abacavir/lamivudine as a switch strategy in subjects with virological suppression
por: Llibre, Josep M, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_92pq0ffct60o7rmllnnu17fehn